Navigation Links
Bird-flu Vaccine Adjuvant Contract Goes to Novartis

Swiss-based global pharmaceutical giant Novartis bagged the contract to make a chemical that would boost the effectiveness of bird-flu vaccines. The $54.8 million contract// was finalised on Wednesday.

The company already has more than $300 million in federal contracts to fight a possible bird-flu outbreak in humans.

Two other firms were also awarded contracts on Wednesday by the U.S. Department of Health and Human Services. GlaxoSmithKline of England got $63.3 million and Iomai of Maryland was given $14.4 million.

The government expects the companies to intensify bird-flu vaccines by employing adjuvants. These increase the body's immune response thereby reducing quantity of vaccine required for protection.

'A vaccine that uses adjuvant could provide a way to extend a limited vaccine supply to more people,' said Health and Human Services Secretary Mike Leavitt said in a statement.

Chicken egg technique is the conventional method of making vaccines but experts find the cell-culture method is faster in producing large quantities of bird-flu vaccine. Novartis received $220.5 million in May, from federal officials to produce a bird-flu vaccine from cell cultures in addition to two other contracts.

'These are all important contracts,' said Novartis spokeswoman Alison Marquiss, 'throwing everything we can at pandemic preparedness.'

Under the contract Novartis will attempt to make a new bird-flu vaccine adjuvant with slight changes in the existing seasonal-flu adjuvant, named MF59. MF59 was developed by Chiron from water and shark liver oil, and is used by older people who need to boost their immune systems.

Health experts opine that two doses of a vaccine might be required to protect someone against H5N1, with 90 micrograms of the antigen in each dose. The dosage of adjuvant required is still not clear.
PRI
'"/>




Page: 1

Related medicine news :

1. H5N1 Bird-flu Confirmed in France
2. Hungry for respite: Bird-flu virus ruffles poultry in Hungary
3. Intelligent Ways to Prevent a Bird-flu Outbreak
4. Daronrix, Glaxos Bird-flu Vaccine Approved by European Medicines Agency
5. Thai’s Health Ministry Stocked To Deal With Any Possible Bird-flu Outbrea
6. Vaccine to quit smoking?
7. First Vaccine Designed for Africa Cleared for Testing in Humans
8. Vaccine for Alzheimer’s diseas
9. Health Officials Recommend Flu Vaccine
10. Smallpox Vaccine May Help Fight Cervical Cancer
11. Panacea Biotech To Market Anthrax Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
Breaking Medicine Technology: